FDA Investigator Lauren E Swantko
Lauren E Swantko has inspections in 9 countries as of 31 Oct 2023. Lauren E Swantko has collaborated with a combined 2948 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
165
Last Inspection Date:
31 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Ireland,
United States of America,
Poland,
Italy,
Canada,
Ukraine,
India,
Serbia,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Aaron J Poloni,
Abigail A Andersen,
Adamsr,
Alan D Grupe,
Aleta T Flores,
Alexander M Kay,
Alicia A Borg Borm,
Anita Narula, PhD,
Anthony E Keller, RPh,
Arie R Dyk,
Ava M Bowman,
Barbara Janine Breithaupt,
Belinda E Clifton,
Beverly A Thomas,
Brenda K Alford,
Bruce R Burrell,
Bryan Baker,
Bryce E Mansfield,
Celeta S Coves,
Celia L Hutchinstein,
Celia L Silverstein,
Christina L Norton,
Christopher R Czajka,
Clinton R Vanblaricom,
Connie P Rezendes,
Dan G Eisenbrey,
Dawn E Barkans,
Deborah Kleinfeld,
Dennis G Kawabata,
Dennis M Farley,
Dennis R Hudson,
Diane Hall,
Dianna D Wardlow Dotter,
Dianne B Latona,
Dipti Kalra,
Dolores E Price,
Don A Leeseberg,
Donald W Jehn,
Dustin P Tran,
Elizabeth E Hart (ASCP), MT,
Elizabeth S Howell,
Emily B Camire,
Eric C Milstead,
Eric L Scott,
Eric T Huebler,
Farhana Khan,
Gabriel M Guevarra,
Garrad R Poole,
Gavin W Pierce,
Gerard Pde Leon,
Gina C Collins,
Gloria A Milster,
Gloria J Baca, MS,
Haley H Seymour,
Harmon M Blanch,
Herbert Arden,
Herbert E Arden,
Hugh Grimoldby,
Hugh M Mcclure, II,
Ismael Olvera, IV,
Jacob N Hamilton,
James A Lane,
James D Eildreth,
James D Hildreth,
James H Robinson,
Jean Brewer,
Jeanne M Weishaar,
Jeffrey J Leclair,
Jessica B Clark,
Jessica L Walters Moell,
Jessie J Deloach,
Jinkee Mvila Binayug,
John A Iwen,
John W Banks,
Jonathan T Little,
Joseph A Seitz,
Julian C Hanson,
Ka L Wong,
Kaitlyn R Kornberg,
Karen M Montgomery (KMM),
Katherine L Arnold,
Kathryn A Krentz,
Kellie L Westerbuhr,
Kelsey A Hustedt,
Kimberly J Proctor Jones,
Kip J Hanks,
Lakecha N Lewis,
Lance M De Souza, MBA,
Lance W Bohm,
Laurissa S Flowers,
Laverne Puckett,
Lawrence Y Lee, PhD,
LCDR Margaret E Digennaro,
Leeterry Moore,
Lesley A Swanson,
Lester O Boian,
Leya A Grosch,
Lisa K Capron,
Lisa M Althar,
Lori J Silverstein,
LTJG Bradley E Benasutti,
Maida Henesian (NMI),
Marc A Jackson, Jr,
Marcus A Goshen,
Margo Cl Jones,
Maria Pkelly Doggett, MBA,
Mark E Imsland,
Mark W Babbitt,
Marlene L Davis,
Mary Ewilkerson Brinsko,
Mary T Carden,
Matthew J Gretkierewicz,
Melissa D Kalik,
Michael F Schuette,
Michael I Gorman,
Michael J Donovan,
Michael S Hudson,
Minh D Phan,
Mpris Inspector,
Narahi J Alvarez Alcazar,
Neil J Traaen,
Peter Kessler, PhD,
Peter T Regan,
Rachel J Cantrell,
Randy L Elsberry,
Raymond W Brullo,
Rebecca A Sletner,
Rebecca T Davis,
Richard J Bashay,
Richard T Riggie,
Robert A Williams,
Robert S Sweeton,
Rocco C Black,
S Lori Brown, PhD MPH,
Sandra S Saniga,
Savini,
Scott Reynolds,
Shannon J Hall,
Shelagh D Schopen,
Shelley H Beausoleil,
Shelley H Roberts,
Sherri N Rohlf, MD,
Stacy A Schneider,
State Agency,
Stephanie A Slater, MS,
Stephen R Souza,
Stephen T Hansen,
Stuart W Russell,
Sunitha K Rajaram, PhD,
Sunny R Muir,
Tania Y Hall,
Thomas C Mclean, CFS,
Timothy P Lafave,
Travis S Bradley,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Vining,
Vitaliy N Guyvan,
William A Burkey,
William J Foust,
Williamsra,
Young M Yoon,
Yvonne C Wilkes,
Zachary P Wachlarowicz
Lauren E Swantko's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2013 | FDA 483 | Boise VAMC - Form 483, 2013-01-24 |
July, 2015 | EIR | David A. Evans, M.D. - EIR, 2015-07-22 |
July, 2012 | EIR | Xtant Medical Holdings Inc - EIR, 2012-07-26 |
April, 2012 | FDA 483 Response | Biomat USA, Inc. - Form 483R, 2012-05-09 |
July, 2015 | FDA 483 | David A. Evans, M.D. - Form 483, 2015-07-22 |
January, 2013 | EIR | Boise VAMC - EIR, 2013-01-24 |
July, 2012 | FDA 483 | Xtant Medical Holdings Inc - Form 483, 2012-07-26 |
July, 2018 | FDA 483 | Olukemi Wallace - Form 483, 2018-07-13 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more